4, 2024 /PRNewswire/ -- Following a successful launch of NASA's SpaceX 31st commercial resupply mission, new scientific experiments and cargo for the agency are bound ... hundreds of investigations ...
Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced the upcoming presentation of preclinical data for ...